NEW YORK, April 05, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Solid Biosciences Inc. ("Solid Biosciences") (NASDAQ:SLDB) pursuant to the January 25, 2018 initial public offering and/or between January 25, 2018 and March 14, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Massachusetts. To get more information go to:
http://www.zlk.com/pslra-d/solid-biosciences-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Solid Bioscience’s lead drug candidate, SGT-001, had a high likelihood of causing adverse events in patients; (2) the company misled investors regarding the toxicity of SGT-001; and (3) consequently, defendants’ statements in the Registration Statement regarding Solid Biosciences’ business, operations, and prospects were materially false and/or misleading.
If you suffered a loss in Solid Biosciences you have until May 29, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Telegram Restored on Apple App Store After Temporary Removal
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 



